Tag: NIH
-
Immune Cell Chips to Launch into Space for Microgravity Tests
Chip devices with human immune system and stem cells are among the cargo set for launch today to the International Space Station.
-
FDA Identifies Database to Evaluate Precision Diagnostics
The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine.
-
NIH Funds Support for Point-of-Care Device Entrepreneurs
Two institutions in Massachusetts are starting a program to help inventors and new enterprises anywhere in the U.S. bring their point-of-care medical devices to market.
-
NIH Award Supports Esophagus Tissue Implants from Stem Cells
A company developing engineered tissue implants from stem cells received a grant from National Institutes of Health to develop an implant to correct a congenital defect in a newborn infant’s esophagus.
-
NIH Stops Stem Cell Heart Failure Trial Over Retracted Data
National Heart, Lung, and Blood Institute, or NHLBI, part of the National Institutes of Health is suspending a clinical trial of stem cells to regenerate new heart muscle.
-
NIH Supporting Electronic Neuro Drug Test Technology
A university spin-off enterprise is receiving funds from National Institute of Mental Health to develop a simple, reliable electronic device to evaluate effects of neurological drugs on brain cells.
-
Model Biotech Materials Sharing Agreement Unveiled
A document with standard legal language for terms and conditions of sharing biotechnology materials is now available for academic and industry research labs.
-
Small Business Grant Aims to Cut Animals in Toxicity Testing
A grant from National Institute of Health supports work by a start-up enterprise in Indiana to better estimate doses needed to test drugs for toxicity and reduce the number of animals needed for those tests.
-
Antibody Combination Shown to Suppress HIV
Results from a small-scale clinical trial show a combination of antibodies can suppress the HIV virus for many weeks after stopping antiretroviral therapy.
-
Genome Centers Named for Precision Medicine Program
Three medical research centers in the U.S. will begin analyzing the DNA in specimen samples from participants in a large-scale precision medicine initiative conducted by National Institutes of Health.